Literature DB >> 12895390

Adaptive randomization in a treatment study of patients with adverse karyotype acute myeloid leukemia.

Elihu H Estey.   

Abstract

Entities:  

Year:  2003        PMID： 12895390     DOI： 10.1007/s11912-003-0024-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  2 in total

1.  Adaptive assignment versus balanced randomization in clinical trials: a decision analysis.

Authors:  D A Berry; S G Eick
Journal:  Stat Med       Date:  1995-02-15       Impact factor: 2.373

Review 2.  Tailoring the treatment of acute myeloid leukemia.

Authors:  A K Burnett
Journal:  Curr Opin Hematol       Date:  1999-07       Impact factor: 3.284
  2 in total
  1 in total

1.  A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy.

Authors:  Michael Lübbert; Björn H Rüter; Rainer Claus; Claudia Schmoor; Mathias Schmid; Ulrich Germing; Andrea Kuendgen; Volker Rethwisch; Arnold Ganser; Uwe Platzbecker; Oliver Galm; Wolfram Brugger; Gerhard Heil; Björn Hackanson; Barbara Deschler; Konstanze Döhner; Anne Hagemeijer; Pierre W Wijermans; Hartmut Döhner
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.